Search

Your search keyword '"Olsson, T"' showing total 2,906 results

Search Constraints

Start Over You searched for: Author "Olsson, T" Remove constraint Author: "Olsson, T"
2,906 results on '"Olsson, T"'

Search Results

2. Pseudo-single-bunch mode for a 100 MHz storage ring serving soft X-ray timing experiments

3. A single overnight infusion of TAK-925, a selective orexin 2 receptor agonist, reduces obstructive sleep apnea severity

6. Effects of TAK-925 (danavorexton) a selective orexin 2 receptor agonist on upper airway collapsibility and pharyngeal muscle activity in adults with obstructive sleep apnea

7. Preparing the MAX IV storage rings for timing-based experiments

8. Bunch length measurements with passive harmonic cavities for non-uniform fill patterns in a 100 MHz RF system

9. Bunch length measurements with passive harmonic cavities for uniform fill patterns in a 100 MHz RF system

12. Locus for severity implicates CNS resilience in progression of multiple sclerosis

13. Smoking and alcohol associated to the risk of developing Myasthenia gravis in a Swedish nationwide prevalent cohort

14. Adapted, Adopted, and Novel Interventions : A Whole-Population Meta-Analytic Replication of Intervention Effects

17. Translational utility of experimental autoimmune encephalomyelitis: recent developments

18. The population genomic legacy of the second plague pandemic

19. ECTRIMS/EAN guideline on the pharmacological treatment of people with multiple sclerosis

25. Humoral and cellular immune responses after SARSCoV-2-Vaccination in a Swedish cohort of persons with multiple sclerosis treated with disease modifying therapies

26. Re-visiting alpha beta-crystallin : EBNA1 antibody crossreactivity and CRYAB-specific T cell responses in multiple sclerosis

27. SARS-COV2 exposure rates and serological response of people living with MS

28. Investigating the T cell response to Anoctamin-2 and Epstein-Barr virus nuclear antigen 1 in multiple sclerosis using antigen-coupled beads

29. Clinical effectiveness and safety of dimethyl fumarate for patients treated at least 6 years in the swedish post-market surveillance study 'immunomodulation and multiple sclerosis epidemiology 5' (IMSE 5)

30. Increase in Epstein Barr virus serologies precedes neuroaxonal damage in pre-symptomatic multiple sclerosis

31. Improved clinical outcomes in patients treated with natalizumab for at least 11 years - real-world data from a swedish national post-marketing surveillance study (IMSE 1)

32. Clinical effectiveness and safety of cladribine tablets for patients treated at least 12 months in the Swedish post-market surveillance study 'immunomodulation and multiple sclerosis epidemiology 10' (IMSE 10)

33. Rapid discontinuation of baclofen as a treatment for spasticity among MS patients with incident and prevalent diagnoses

34. Natural hazards and extreme events in the Baltic Sea region

38. Glutamate Induced Astroglial Swelling — Methods and Mechanisms

39. Long-term effects of a Palaeolithic-type diet in obese postmenopausal women: a 2-year randomized trial

45. Cerebrospinal fluid analysis Clinical neurochemistry

Catalog

Books, media, physical & digital resources